Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Fertil Steril. 2010 May 1;93(7):2441-3. doi: 10.1016/j.fertnstert.2009.08.062. Epub 2009 Dec 4.

    Prevalence of antiphospholipid antibodies among women experiencing unexplained infertility and recurrent implantation failure.

    Source

    National Institute of Perinatology, Mexico City, Mexico.

    Abstract

    The prevalences of antiphospholipid antibodies (APAs) among 1,325 women with a history of unexplained infertility and 676 women experiencing recurrent implantation failure were compared with 789 women experiencing recurrent pregnancy loss and 205 fertile control women. Eight percent and 9% of women with a history of unexplained infertility and recurrent implantation failure had more than one positive APA compared with 1.5% of fertile negative control women and 11% of positive control women experiencing recurrent pregnancy loss.

    Copyright 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

    PMID:
    19962695
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk